Member Info for Aldebaran

Jen did you or did you not already believe the tech was validated?

Indeed JW himself said it had been validated through our S&P500 partner so I think we didnt really need this from komatsu though its nice to have. Infact if it really was so significant dont you think the SP would be materially higher and not falling back already being sold into like it always is... ?

Im not expecting huge sales yet, I dont think we'll see them until 2027 to be realistic. So in the meantime there will be pops drops and trading ops. This i believe is one of them

Ade if you believe AFC is fairly valued can you provide calcs to back that up? Have you done risk adjusted NPV calcs or anything or is this just a gut feel? Personally I think the value is quite lofty but everyone has a opinion is guess and we'll all be different. Thats why im interested if you've run the numbers to back yours up.

Based on getting 5% market share by say 2031 etc then discount back to today. I run similar numbers for another company and it shocked me how overvalued it actually was and that suddenly made sense why no instituons we're onboarding in any serious way. The company valuation later plummeted

Its great we have komatsu interested but for me we dont need any more technology validation. I and almost all of you believe the S&P 500 partner as validated it anyway. Weve had partners and letters of intent and JDA's before and look where we ended up.

2m is nice but it's loose change. For afc a company with a market cap of approx 150m then frankly it's nothing. It may lead to more of course but right now its peanuts. What We need for a sustainable rerate is material sales. This type of news is what excites small fry retail investors and the bigger smarter money sells into IMO.

Does anyone know what time frame that 2m is over as well or is it a question for 27th Feb ? Id like to know if we have it in the bank upfront (doubtful) or whether it is paid in installments over say 2years (likely) which makes it even more negligible.

Not knocking the progress, it is good but not what we really need is what im saying

Chancery dont get paid a cent until we get dividends.

Cant emphasise how fantastic that deal is. Well effing done Harry. Now, with company trading at a mere fraction of its NPV of 17p based of today's gold price then you have catalysts for growth and dividends and of course the gold price likely to go even higher at least in the short term.

Kefi is best opportunity on AIM right now imv

Jhfh its not me honestly hemo doesnt livenin my head rent free nor am I obsessed with or in love or hate it. I feel nothing for it. Its like any other share. A vehicle or making money. There are much better ones and some not so good out there. I have hemo in the lower quartile trading share thats all. Been making a fortune on precious metals with the money in took out here at 1600p. I really could not care less what happens here to shareholders as none of you are researched enough imo. Hope the product makes it to maket tho.

Anyway I got money to make, cant be sat here all day every day filling in the huge blanks vlad leaves in his RNS's...

Later skater ✌🏾

Anyone put a value on the silver deposits yet?

Pumpkin clearly the placees are dumping making a nice turn. Sad thing is its those very same people here day in day out telling everyone how cheap hemo is.

Questions that any serious investors should be asking

What is current condition of all 3 patients

When will tech transfer complete and trial resume

When will there be any news from Estonia, will there be or have talks broken down?

Why did hemo only raise 2.5m when it was made clear a minimum of 5 6m was required for 2026 just to progress HG-CT-1

Why did placees insist on yet more warrants and why were they granted if the company is so undervalued and so close to a deal with farmer

If you don't know the answers to the above you are gambling not investing

Uk housing sector is weak af. Of all the industries to invest in like precious metals, AI, energy, defence etc... what on earth is the attraction to housing. Good balance sheet here and doing houses at the cheaper end of the scale but with millionaires leaving in droves taking jobs with them and uk government hell bent on accelerating this economic doom loop who is left to buy and afford houses anyway?

Its due Mr Adams. I forgive you for taking a bit longer than expected to get this over the line but its done now.

Amd with all in sustainable costs at less than $1.5k per ounce then this is am absolute gold mine at even just $3k per ounce. Pun intended.

The rerate is now underway. The train is leaving the station now. Excellent

Great to hear Harry talking of dividends. I have not seen before a royalty agreement that doesnt get any money back until shareholders get dividends. Credit where

Risk adjusted net present value here is something like 5p MINIMUM from memory can anyone confirm?

Gold rising again increasing this even further. Compared to a share price of 1.5p I think we go pretty well over this week and next at least.

The amount of free cash flow this mine chucks off exceeds our market cap plus nothing from Saudi factored in. Happy days

So with Chancery heading to Tulu kapi on Friday but leaving next Wednesday that leaves only Monday or Tuesday as announcement day giving Friday this week & Monday next as 2 last possible days to buy in anticipation of the announcement. We've been assured its a formality. The hardest bit (bank funding) is done and gold has stableized now, dare I say even starting a tentative march back UP.

Hopefully see increased volume and buying pressure as the deadline approaches. Im slowly but cautiously strapping in

The year is 2159, tech transfer still hasn't completed. There are now more warrants outstanding than there are stars in the sky. Moorscloud's great grandchildren believe patient 1 is 385 years old 😅

Crying out loud you have no idea if ANY of the patients are still alive. Remember in July 2025 vlad was gushing about the fact they were and in August. Silence and has not mentioned there condition since.

You lot crack me up l.

2.5m raised with warrants again by people who claim over and over that the company is cheap. When it comes to investing there own cash though its a different story.

Now, vlad said he needed approx 16m from memory just to complete HG-CT-1 phase 1. So another 13.5m to raise.

How much money and effort is directed at CBR and CDX ? When are big farmer going to put pen to paper, when will the trial resume, when will we get a update on Estonia?

Zero answers but the one thing vlad is clear about is the requirement for cash

If vlad as the ears of people with a lot more money why hasn't he raised enough to cover 1 year of expenses? Why only roughly 6 months.

If big farmer are queuing up to sign up with vlad why haven't they?

When is the non binding letter of intent for Estonia going to translate into anything material, will it even?

How long will tech transfer take and when will we recomence HG-CT-1 trials.

Are the 3 patients still alive???

No update on anything other than how much cash he needs. As always with vlad. Pathetic. Only people loving this update are those that are under water and have too pretend.

2.5m is nowhere near enough. Big farmer not interested.

JHFH is mugging you all off time and time again.

Big pharma are NOT interested at this stage clearly. So let's cut the c r ap.

Any news on Estonia and the non binding letter of intent that was being ramped as a mega commercial opportunity. No of course not.

Do we know if the 3 patients treated so far are still alive. Nope.

Do we know or have ANY idea how long tech transfer is going to take. No!

Only thing vlad made clear in the last prospectus is that hemo needed over 15m to complete the trial. On that point he was crystal clear.

But the big question is if this is such a no brainer and such a cheap company. Why the big discount and why on earth again do the placees INSIST on warrants to boot. Their taking the p1 ss.

Another fundraise required this year is not great thing to realise the moment rns comes out saying they've just raised funds.

How much of this money is going to cbx and cbr as well? Because the 5.6m needed this year was purely for HG-CT-1...

As ever a hemo rns raises more questions than it gives answers

And when is tech transfer going to complete?? Pmsl

Sizeable discount from yesterday's closing price and with warrants to boot. These have all of course gone to the very people ramping the a s s off this who frequent these bulletin boards preying on naive investors. Y'all know who I am referring too.

Anyway. Company needed 5.6m for this year from memory so this amount raised still isnt enough. And it needs over 15m minimum to complete HG-CT-1 trial. Another raise in what 6 months max? Pharma not interested yet either then despite all the ramps.

Im saying same thing that deal will be on faridoxorubicin based off the 4 years of dada we have for sts sgc and also breast cancer plus the work done on 3996 amd 6207 in pre clinical setting. Throw into the mix some initial data from 6103 and it becomes a self validating loop. 6103 is actually validating 6000 which itself is derisking 6103.

Its highly unique. I am expecting 6103 data ans breast cancer data to lead to a deal or as some have said maybe even a direct take out approach. Could be well before market sets eyes on 6103 data... not giving the market and FUDsters chance to react and buy in "cheap". Before the deals land. Be a massive shame that but id get over it

Us plebs may have to wait until June earliest but how long before those under NDA such as presumably Novartis et al get to see it ? What do you think touk?

2nd question, how long before initial scans and tolerability is known after dosing. Initial i am saying. Given exetecan is what 20x more potent than irinotecan and 100x more potent than doxorubicin and more permeable than deruxtecan etc... ??

Personally I think within 1 months off dosing then the initial safety will be known and their could easily he signs of efficacy. This will be WAY before June and the point the market gets said data.

Could a deal be signed off the back of this and the faridoxorubicin data to date before the market catches on, i think its possible. Highly possible actually. You and others? Thinking what?

The share price doesnt lie and anytime news is released it is used as exit liquidity by those without rose tinted glasses